Walleye Capital’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212K Buy
+2,100
New +$217K ﹤0.01% 3466
2025
Q2
Sell
-2,000
Closed -$203K 4621
2025
Q1
$203K Sell
2,000
-2,200
-52% -$215K ﹤0.01% 3254
2024
Q4
$388K Sell
4,200
-600
-13% -$58.9K ﹤0.01% 3205
2024
Q3
$464K Buy
4,800
+3,400
+243% +$306K ﹤0.01% 3362
2024
Q2
$120K Buy
1,400
+100
+8% +$8.39K ﹤0.01% 4630
2024
Q1
$107K Buy
+1,300
New +$95.2K ﹤0.01% 4359
2023
Q4
Sell
-4,300
Closed -$289K 5085
2023
Q3
$289K Buy
+4,300
New +$296K ﹤0.01% 3271
2020
Q1
Sell
-1,257
Closed -$69K 1131
2019
Q4
$69K Buy
+1,257
New +$68.2K ﹤0.01% 1449

Other funds holding EHC

Walleye Capital's EHC Position: Q2 2026 in Review

Walleye Capital opened a new position in Encompass Health (EHC) in Q2 2026: 224 shares worth $22.6K. The stake represents ﹤0.01% of the portfolio and ranks #4363 among its holdings. This is a return to the name: Walleye Capital previously reported a position in EHC as recently as Q3 2025.

Walleye Capital first reported a position in EHC in Q4 2019 and has held it in 12 quarters since. The position peaked at $800K in Q2 2025. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Walleye Capital held 224 shares of Encompass Health worth $22.6K as of Q2 2026.
  • Encompass Health was a new Walleye Capital position in Q2 2026.
  • Encompass Health made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4363 holding.
  • Walleye Capital first reported a position in Encompass Health in Q4 2019 and has held it in 12 quarters since.
  • Walleye Capital's Encompass Health position peaked at $800K in Q2 2025.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.